Health
Trump’s Drug Pricing Policy Deprives Patients in Europe of New Treatments
Rather than endanger their US profits, drugmakers withhold new medicines
Frank Hennemann sometimes coughs 400 times a day. His airways are damaged by a lung condition called bronchiectasis, which he describes as feeling like two trucks are parking on his chest.
After decades of research, there’s finally a medicine to alleviate his symptoms, but Hennemann lives in Germany. One reason he can’t get it there is Donald Trump.